Skip to main content
. 2020 Sep 19;22(11):29. doi: 10.1007/s11908-020-00739-6

Table 1.

Demographic and clinical data of children diagnosed with COVID-19

Lu et al. (China) (N = 171) [16] Dong et al. (China) (N = 728) a [2] CDC MMWR (US) (N = 2572) b [3] Götzinger et al. (Europe) (N = 582) [17] Parri et al. (Italy) (N = 100) [15]
Median age in years (IQR) 6.7 (N/A) 10 (4–15) 11 (N/A) 5 (0.5–12) 3.3 (N/A)
Patients < 1 years (%) 18.1 11.7 15 29 40
Male/female ratio 1.55 1.3 1.3 1.15 1.3
Asymptomatic (%) 16 4.4 23 16 21
Fever (%) 37.5/6–38 °C 9.4 N/A 56 65 15
38.1–39.0 °C 22.8 28
> 39.0 °C 9.4 11
Cough (%) 48.5 N/A 54.3 N/A 44
Shortness of breath (%) N/A N/A 13 N/A 11
Upper respiratory tract symptoms (%) Rhinorrhea 7.6 N/A 7.2 54c 22
Sore throat or pharyngeal erythema 46.2 N/A 24.4 4
Clinical or radiological evidence of pneumonia (%) 65 N/A N/A 47 N/A
Gastrointestinal symptoms (%) Nausea/vomiting 6.4 N/A 11 22 10
Diarrhea 8.8 N/A 13 9
Abdominal pain N/A N/A 5.8 4
Headache (%) N/A N/A 28 28 4
ICU admissions (%) 1.8 0.4 2 8.2 9
Deaths (n, %) 1 (0.6) 1 (0.14) 3 (0.12) 4 (0.7) 0 (0)

CDC Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report, MMWR Morbidity and Mortality Weekly Report, US United States, ICU intensive care unit, N/A not available

aData on confirmed cases (the report included also suspected cases)

bData on signs and symptoms of COVID-19 were available for 291/2572 patients

cUpper respiratory infection included coryza, tonsillitis, sore throat, otitis media and sinusitis